[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$faMIcJprK1xSHjR1e160Jh6drq97uU8LIvHkH4CnsTcI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":66,"rows":73},"Geisinger Clinic",[4],120,false,17,1,1395345,9,103,[14,17,20,23,26,29,31,34],{"name":15,"count":16},"Obesity",10,{"name":18,"count":19},"Health Promotion",8,{"name":21,"count":22},"Health Behavior",6,{"name":24,"count":25},"Influenza",5,{"name":27,"count":28},"Hypertension",4,{"name":30,"count":28},"Emergency Service, Hospital",{"name":32,"count":33},"Albuminuria",3,{"name":35,"count":33},"Cardiovascular Diseases",[37,42,46,51,56,61],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05862792","Liposomal Bupivacaine and Transoral Robotic Surgery","2025-12-31","Liposomal bupivacaine",{"nctId":43,"briefTitle":44,"date":40,"intervention":45},"NCT05464615","Geisinger Antibiotic Allergy Pilot Program: Assess and Address","Amoxicillin",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT06936709","Perioperative Colchicine for TKA","2026-01-01","Colchicine 1.8 mg (loading dose) + Dextrose Oral Placebo",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT05091879","Preemptive Pharmacogenomics Testing Among Geriatric Patients","2026-06","Multigene pharmacogenomics test",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT04863222","Clinical and Radiographic Success of MTA vs Biodentine","2026-08-01","mineral trioxide aggregate",{"nctId":62,"briefTitle":63,"date":64,"intervention":65},"NCT07583862","The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial","2028-07","Topical Timolol",[67,68,69,70,71,72],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[74,99,126,144,162,186,204,225,265,288,313,340,358,386,411,435,459,484,516,534,552,570,588,606,632],{"intervention":60,"totalTrials":9,"cells":75},{"EARLY_PHASE1":76,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":85,"NA":97},{"trials":77,"activeCount":78},[],0,{"trials":80,"activeCount":78},[],{"trials":82,"activeCount":78},[],{"trials":84,"activeCount":78},[],{"trials":86,"activeCount":9,"soonestReadout":59},[87],{"nctId":57,"briefTitle":58,"status":88,"phases":89,"primaryCompletion":59,"completion":90,"start":91,"enrollment":92,"conditions":93,"interventions":96},"RECRUITING",[71],"2026-12-01","2021-11-12",646,[94,95],"Indirect Pulp Cap","Pulpotomy",[60],{"trials":98,"activeCount":78},[],{"intervention":50,"totalTrials":9,"cells":100},{"EARLY_PHASE1":101,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":124},{"trials":102,"activeCount":78},[],{"trials":104,"activeCount":78},[],{"trials":106,"activeCount":78},[],{"trials":108,"activeCount":78},[],{"trials":110,"activeCount":9,"soonestReadout":49},[111],{"nctId":47,"briefTitle":48,"status":112,"phases":113,"primaryCompletion":49,"completion":114,"start":115,"enrollment":116,"conditions":117,"interventions":121},"NOT_YET_RECRUITING",[71],"2026-03-01","2025-12-01",75,[118,119,120],"Osteoarthritis of Knee","Recovery Following Primary Total Knee Arthroplasty","Perioperative Pain Control",[50,122,123],"Colchicine 1.8 mg + 0.6 mg","Dextrose Oral Placebo",{"trials":125,"activeCount":78},[],{"intervention":122,"totalTrials":9,"cells":127},{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":134,"PHASE4":136,"NA":142},{"trials":129,"activeCount":78},[],{"trials":131,"activeCount":78},[],{"trials":133,"activeCount":78},[],{"trials":135,"activeCount":78},[],{"trials":137,"activeCount":9,"soonestReadout":49},[138],{"nctId":47,"briefTitle":48,"status":112,"phases":139,"primaryCompletion":49,"completion":114,"start":115,"enrollment":116,"conditions":140,"interventions":141},[71],[118,119,120],[50,122,123],{"trials":143,"activeCount":78},[],{"intervention":123,"totalTrials":9,"cells":145},{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":152,"PHASE4":154,"NA":160},{"trials":147,"activeCount":78},[],{"trials":149,"activeCount":78},[],{"trials":151,"activeCount":78},[],{"trials":153,"activeCount":78},[],{"trials":155,"activeCount":9,"soonestReadout":49},[156],{"nctId":47,"briefTitle":48,"status":112,"phases":157,"primaryCompletion":49,"completion":114,"start":115,"enrollment":116,"conditions":158,"interventions":159},[71],[118,119,120],[50,122,123],{"trials":161,"activeCount":78},[],{"intervention":65,"totalTrials":9,"cells":163},{"EARLY_PHASE1":164,"PHASE1":166,"PHASE2":168,"PHASE3":180,"PHASE4":182,"NA":184},{"trials":165,"activeCount":78},[],{"trials":167,"activeCount":78},[],{"trials":169,"activeCount":9,"soonestReadout":64},[170],{"nctId":62,"briefTitle":63,"status":112,"phases":171,"primaryCompletion":64,"completion":172,"start":173,"enrollment":174,"conditions":175,"interventions":178},[69],"2029-03","2026-07-01",40,[176,177],"Surgical Wounds","Mohs Surgery",[65,179],"Normal Saline",{"trials":181,"activeCount":78},[],{"trials":183,"activeCount":78},[],{"trials":185,"activeCount":78},[],{"intervention":179,"totalTrials":9,"cells":187},{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":198,"PHASE4":200,"NA":202},{"trials":189,"activeCount":78},[],{"trials":191,"activeCount":78},[],{"trials":193,"activeCount":9,"soonestReadout":64},[194],{"nctId":62,"briefTitle":63,"status":112,"phases":195,"primaryCompletion":64,"completion":172,"start":173,"enrollment":174,"conditions":196,"interventions":197},[69],[176,177],[65,179],{"trials":199,"activeCount":78},[],{"trials":201,"activeCount":78},[],{"trials":203,"activeCount":78},[],{"intervention":45,"totalTrials":9,"cells":205},{"EARLY_PHASE1":206,"PHASE1":215,"PHASE2":217,"PHASE3":219,"PHASE4":221,"NA":223},{"trials":207,"activeCount":9,"soonestReadout":40},[208],{"nctId":43,"briefTitle":44,"status":88,"phases":209,"primaryCompletion":40,"completion":40,"start":210,"enrollment":211,"conditions":212,"interventions":214},[67],"2024-03-04",100,[213],"Penicillin Allergy",[45],{"trials":216,"activeCount":78},[],{"trials":218,"activeCount":78},[],{"trials":220,"activeCount":78},[],{"trials":222,"activeCount":78},[],{"trials":224,"activeCount":78},[],{"intervention":41,"totalTrials":226,"cells":227},2,{"EARLY_PHASE1":228,"PHASE1":230,"PHASE2":232,"PHASE3":234,"PHASE4":236,"NA":252},{"trials":229,"activeCount":78},[],{"trials":231,"activeCount":78},[],{"trials":233,"activeCount":78},[],{"trials":235,"activeCount":78},[],{"trials":237,"activeCount":78},[238],{"nctId":239,"briefTitle":240,"status":241,"phases":242,"primaryCompletion":243,"completion":243,"start":244,"enrollment":9,"conditions":245,"interventions":250},"NCT03922620","Liposomal Bupivacaine vs Peripheral Nerve Block","TERMINATED",[71],"2021-06-30","2020-01-23",[246,247,248,249],"Pain, Acute","Surgery","Anesthesia","Opioid Use",[41,251],"Peripheral Nerve Block",{"trials":253,"activeCount":9,"soonestReadout":40},[254],{"nctId":38,"briefTitle":39,"status":88,"phases":255,"primaryCompletion":40,"completion":256,"start":257,"enrollment":258,"conditions":259,"interventions":264},[],"2026-01-15","2023-06-01",80,[260,261,262,263],"Oropharyngeal Cancer","Dysphagia, Oropharyngeal","Post Operative Pain","Transoral Robotic Surgery",[41],{"intervention":55,"totalTrials":9,"cells":266},{"EARLY_PHASE1":267,"PHASE1":269,"PHASE2":271,"PHASE3":273,"PHASE4":275,"NA":277},{"trials":268,"activeCount":78},[],{"trials":270,"activeCount":78},[],{"trials":272,"activeCount":78},[],{"trials":274,"activeCount":78},[],{"trials":276,"activeCount":78},[],{"trials":278,"activeCount":9,"soonestReadout":54},[279],{"nctId":52,"briefTitle":53,"status":280,"phases":281,"primaryCompletion":54,"completion":54,"start":282,"enrollment":283,"conditions":284,"interventions":287},"ACTIVE_NOT_RECRUITING",[72],"2023-03-28",66,[285,286],"Polypharmacy","Pharmacogenomic Testing",[55],{"intervention":289,"totalTrials":9,"cells":290},"Semaglutide",{"EARLY_PHASE1":291,"PHASE1":293,"PHASE2":295,"PHASE3":297,"PHASE4":299,"NA":311},{"trials":292,"activeCount":78},[],{"trials":294,"activeCount":78},[],{"trials":296,"activeCount":78},[],{"trials":298,"activeCount":78},[],{"trials":300,"activeCount":78},[301],{"nctId":302,"briefTitle":303,"status":241,"phases":304,"primaryCompletion":305,"completion":306,"start":307,"enrollment":33,"conditions":308,"interventions":310},"NCT04624672","Treatment of GLP-1 for Diabetic Bariatric Patients",[71],"2022-07-18","2022-08-17","2021-08-25",[309],"Diabetes Mellitus, Type 2",[289],{"trials":312,"activeCount":78},[],{"intervention":314,"totalTrials":9,"cells":315},"Buffered Lidocaine",{"EARLY_PHASE1":316,"PHASE1":318,"PHASE2":320,"PHASE3":322,"PHASE4":324,"NA":338},{"trials":317,"activeCount":78},[],{"trials":319,"activeCount":78},[],{"trials":321,"activeCount":78},[],{"trials":323,"activeCount":78},[],{"trials":325,"activeCount":78},[326],{"nctId":327,"briefTitle":328,"status":329,"phases":330,"primaryCompletion":331,"completion":332,"start":333,"enrollment":334,"conditions":335,"interventions":337},"NCT04055116","Buffered Lidocaine in the Pediatric Dental Patient","COMPLETED",[71],"2021-12-17","2022-03-01","2019-11-11",64,[336],"Pediatric Dentistry",[314],{"trials":339,"activeCount":78},[],{"intervention":251,"totalTrials":9,"cells":341},{"EARLY_PHASE1":342,"PHASE1":344,"PHASE2":346,"PHASE3":348,"PHASE4":350,"NA":356},{"trials":343,"activeCount":78},[],{"trials":345,"activeCount":78},[],{"trials":347,"activeCount":78},[],{"trials":349,"activeCount":78},[],{"trials":351,"activeCount":78},[352],{"nctId":239,"briefTitle":240,"status":241,"phases":353,"primaryCompletion":243,"completion":243,"start":244,"enrollment":9,"conditions":354,"interventions":355},[71],[246,247,248,249],[41,251],{"trials":357,"activeCount":78},[],{"intervention":359,"totalTrials":9,"cells":360},"Semaglutide 2 mg\u002F1.5 ml (1.34 mg\u002Fml), prefilled pen-injector for subcutaneous injection solution",{"EARLY_PHASE1":361,"PHASE1":363,"PHASE2":365,"PHASE3":367,"PHASE4":382,"NA":384},{"trials":362,"activeCount":78},[],{"trials":364,"activeCount":78},[],{"trials":366,"activeCount":78},[],{"trials":368,"activeCount":78},[369],{"nctId":370,"briefTitle":371,"status":241,"phases":372,"primaryCompletion":373,"completion":373,"start":374,"enrollment":375,"conditions":376,"interventions":381},"NCT04741074","Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy",[70],"2023-01-31","2021-07-23",15,[377,378,379,15,380],"CKD","Diabetic Kidney Disease","Type 2 Diabetes Mellitus in Obese","Severe Obesity",[359],{"trials":383,"activeCount":78},[],{"trials":385,"activeCount":78},[],{"intervention":387,"totalTrials":9,"cells":388},"Drug Therapy with Temozolomide",{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":405,"PHASE4":407,"NA":409},{"trials":390,"activeCount":78},[],{"trials":392,"activeCount":78},[],{"trials":394,"activeCount":78},[395],{"nctId":396,"briefTitle":397,"status":241,"phases":398,"primaryCompletion":399,"completion":399,"start":400,"enrollment":226,"conditions":401,"interventions":404},"NCT04209790","Neoadjuvant Chemoradiation for Resectable Glioblastoma",[69],"2022-09-14","2020-04-01",[402,247,403],"Glioblastoma","High Grade Glioma",[387],{"trials":406,"activeCount":78},[],{"trials":408,"activeCount":78},[],{"trials":410,"activeCount":78},[],{"intervention":412,"totalTrials":9,"cells":413},"Erlotinib",{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":429,"PHASE4":431,"NA":433},{"trials":415,"activeCount":78},[],{"trials":417,"activeCount":78},[],{"trials":419,"activeCount":78},[420],{"nctId":421,"briefTitle":422,"status":241,"phases":423,"primaryCompletion":424,"completion":424,"start":425,"enrollment":28,"conditions":426,"interventions":428},"NCT00750555","Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer",[69],"2009-12","2008-09",[427],"Head and Neck Cancer",[412],{"trials":430,"activeCount":78},[],{"trials":432,"activeCount":78},[],{"trials":434,"activeCount":78},[],{"intervention":436,"totalTrials":9,"cells":437},"Ascorbic Acid",{"EARLY_PHASE1":438,"PHASE1":440,"PHASE2":451,"PHASE3":453,"PHASE4":455,"NA":457},{"trials":439,"activeCount":78},[],{"trials":441,"activeCount":78},[442],{"nctId":443,"briefTitle":444,"status":329,"phases":445,"primaryCompletion":446,"completion":446,"start":447,"enrollment":22,"conditions":448,"interventions":450},"NCT03123107","Vitamin C in Cardiac Surgery Patients",[68],"2019-05-31","2017-07-06",[449],"Coronary Artery Bypass Graft Surgery",[436],{"trials":452,"activeCount":78},[],{"trials":454,"activeCount":78},[],{"trials":456,"activeCount":78},[],{"trials":458,"activeCount":78},[],{"intervention":460,"totalTrials":9,"cells":461},"Oxygen",{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":476,"PHASE3":478,"PHASE4":480,"NA":482},{"trials":463,"activeCount":78},[],{"trials":465,"activeCount":78},[466],{"nctId":467,"briefTitle":468,"status":241,"phases":469,"primaryCompletion":470,"completion":471,"start":472,"enrollment":28,"conditions":473,"interventions":475},"NCT01298921","A Pilot Study of Demand Valve Oxygen Inhalation Therapy for Cluster Headache",[68],"2012-06","2012-07","2011-01",[474],"Cluster Headache",[460,460],{"trials":477,"activeCount":78},[],{"trials":479,"activeCount":78},[],{"trials":481,"activeCount":78},[],{"trials":483,"activeCount":78},[],{"intervention":485,"totalTrials":9,"cells":486},"Child(ren) receive an adult-onset result",{"EARLY_PHASE1":487,"PHASE1":506,"PHASE2":508,"PHASE3":510,"PHASE4":512,"NA":514},{"trials":488,"activeCount":78},[489],{"nctId":490,"briefTitle":491,"status":329,"phases":492,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":496,"interventions":500},"NCT03832985","Pediatric Reporting of Adult-Onset Genomic Results",[67],"2024-10-31","2020-11-25",162,[497,498,499],"Hereditary Breast and Ovarian Cancer Syndrome","Lynch Syndrome","Familial Hypercholesterolemia",[485,501,502,503,504,505],"Child(ren) received a pediatric-onset result","Control - Negative Result","Adolescents who received adult-onset result","Adolescents who received a pediatric-onset result","Adolescent controls - negative for familial variant",{"trials":507,"activeCount":78},[],{"trials":509,"activeCount":78},[],{"trials":511,"activeCount":78},[],{"trials":513,"activeCount":78},[],{"trials":515,"activeCount":78},[],{"intervention":501,"totalTrials":9,"cells":517},{"EARLY_PHASE1":518,"PHASE1":524,"PHASE2":526,"PHASE3":528,"PHASE4":530,"NA":532},{"trials":519,"activeCount":78},[520],{"nctId":490,"briefTitle":491,"status":329,"phases":521,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":522,"interventions":523},[67],[497,498,499],[485,501,502,503,504,505],{"trials":525,"activeCount":78},[],{"trials":527,"activeCount":78},[],{"trials":529,"activeCount":78},[],{"trials":531,"activeCount":78},[],{"trials":533,"activeCount":78},[],{"intervention":502,"totalTrials":9,"cells":535},{"EARLY_PHASE1":536,"PHASE1":542,"PHASE2":544,"PHASE3":546,"PHASE4":548,"NA":550},{"trials":537,"activeCount":78},[538],{"nctId":490,"briefTitle":491,"status":329,"phases":539,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":540,"interventions":541},[67],[497,498,499],[485,501,502,503,504,505],{"trials":543,"activeCount":78},[],{"trials":545,"activeCount":78},[],{"trials":547,"activeCount":78},[],{"trials":549,"activeCount":78},[],{"trials":551,"activeCount":78},[],{"intervention":503,"totalTrials":9,"cells":553},{"EARLY_PHASE1":554,"PHASE1":560,"PHASE2":562,"PHASE3":564,"PHASE4":566,"NA":568},{"trials":555,"activeCount":78},[556],{"nctId":490,"briefTitle":491,"status":329,"phases":557,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":558,"interventions":559},[67],[497,498,499],[485,501,502,503,504,505],{"trials":561,"activeCount":78},[],{"trials":563,"activeCount":78},[],{"trials":565,"activeCount":78},[],{"trials":567,"activeCount":78},[],{"trials":569,"activeCount":78},[],{"intervention":504,"totalTrials":9,"cells":571},{"EARLY_PHASE1":572,"PHASE1":578,"PHASE2":580,"PHASE3":582,"PHASE4":584,"NA":586},{"trials":573,"activeCount":78},[574],{"nctId":490,"briefTitle":491,"status":329,"phases":575,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":576,"interventions":577},[67],[497,498,499],[485,501,502,503,504,505],{"trials":579,"activeCount":78},[],{"trials":581,"activeCount":78},[],{"trials":583,"activeCount":78},[],{"trials":585,"activeCount":78},[],{"trials":587,"activeCount":78},[],{"intervention":505,"totalTrials":9,"cells":589},{"EARLY_PHASE1":590,"PHASE1":596,"PHASE2":598,"PHASE3":600,"PHASE4":602,"NA":604},{"trials":591,"activeCount":78},[592],{"nctId":490,"briefTitle":491,"status":329,"phases":593,"primaryCompletion":493,"completion":493,"start":494,"enrollment":495,"conditions":594,"interventions":595},[67],[497,498,499],[485,501,502,503,504,505],{"trials":597,"activeCount":78},[],{"trials":599,"activeCount":78},[],{"trials":601,"activeCount":78},[],{"trials":603,"activeCount":78},[],{"trials":605,"activeCount":78},[],{"intervention":607,"totalTrials":9,"cells":608},"Oxytocin",{"EARLY_PHASE1":609,"PHASE1":611,"PHASE2":613,"PHASE3":615,"PHASE4":617,"NA":619},{"trials":610,"activeCount":78},[],{"trials":612,"activeCount":78},[],{"trials":614,"activeCount":78},[],{"trials":616,"activeCount":78},[],{"trials":618,"activeCount":78},[],{"trials":620,"activeCount":78},[621],{"nctId":622,"briefTitle":623,"status":329,"phases":624,"primaryCompletion":625,"completion":626,"start":627,"enrollment":628,"conditions":629,"interventions":631},"NCT01973036","FOLCROM Trial: Foley Catheter in Rupture of Membranes",[72],"2016-07","2016-08","2014-03",201,[630],"Premature Rupture of Membranes",[607],{"intervention":633,"totalTrials":9,"cells":634},"Nitrous Oxide",{"EARLY_PHASE1":635,"PHASE1":637,"PHASE2":639,"PHASE3":641,"PHASE4":643,"NA":645},{"trials":636,"activeCount":78},[],{"trials":638,"activeCount":78},[],{"trials":640,"activeCount":78},[],{"trials":642,"activeCount":78},[],{"trials":644,"activeCount":78},[],{"trials":646,"activeCount":78},[647],{"nctId":648,"briefTitle":649,"status":329,"phases":650,"primaryCompletion":651,"completion":652,"start":653,"enrollment":654,"conditions":655,"interventions":656},"NCT05890898","Virtual Reality vs Nitrous Oxide in Pediatric Dentistry",[72],"2024-07-05","2024-11-20","2023-09-19",62,[336],[633]]